FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Stem Cells Int / The Effect of Chronic Inflammation and Oxidative and Endopla...
Stem cells international2018; 2018; 4274361; doi: 10.1155/2018/4274361

The Effect of Chronic Inflammation and Oxidative and Endoplasmic Reticulum Stress in the Course of Metabolic Syndrome and Its Therapy.

Abstract: Metabolic syndrome (MetS) is highly associated with a modern lifestyle. The prevalence of MetS has reached epidemic proportion and is still rising. The main cause of MetS and finally type 2 diabetes occurrence is excessive nutrient intake, lack of physical activity, and inflammatory cytokines secretion. These factors lead to redistribution of body fat and oxidative and endoplasmic reticulum (ER) stress occurrence, resulting in insulin resistance, increase adipocyte differentiation, and much elevated levels of proinflammatory cytokines. Cellular therapies, especially mesenchymal stem cell (MSC) transplantation, seem to be promising in the MetS and type 2 diabetes treatments, due to their immunomodulatory effect and multipotent capacity; adipose-derived stem cells (ASCs) play a crucial role in MSC-based cellular therapies. In this review, we focused on etiopathology of MetS, especially on the crosstalk between chronic inflammation, oxidative stress, and ER stress and their effect on MetS-related disease occurrence, as well as future perspectives of cellular therapies. We also provide an overview of therapeutic approaches that target endoplasmic reticulum and oxidative stress.
Get Full Text
Publication Date: 2018-10-22 PubMed ID: 30425746PubMed Central: PMC6217741DOI: 10.1155/2018/4274361Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about the role of chronic inflammation and certain types of cellular stress in the development and treatment of Metabolic Syndrome (MetS), a disease often linked with modern lifestyle habits. The study also examines the promising role cellular therapies, particularly mesenchymal stem cell transplantation, can play in treating MetS and related conditions like type 2 diabetes.

Etiopathology of MetS

  • The chief cause behind the onset of MetS, which often leads to type 2 diabetes, is excess consumption of nutrients, physical inactivity and secretion of inflammatory cytokines. These drivers result in the redistribution of body fat, and induce oxidative and endoplasmic reticulum stress. The latter two conditions contribute to insulin resistance, boost adipocyte differentiation, and result in considerably increased levels of proinflammatory cytokines.
  • This research emphasizes the complex relationship between chronic inflammation, oxidative stress, and endoplasmic reticulum (ER) stress with the prevalence of diseases linked to MetS. Interfering with any of these processes could lead to a change in the body’s metabolic behavior, and hence impact the occurrence of metabolic syndrome-related diseases.

Cellular Therapies for MetS

  • The study discusses the potential of cellular therapies, specifically focusing on mesenchymal stem cell (MSC) transplantation, for treating MetS and type 2 diabetes. MSCs have high relevance in this context due to their immunomodulatory properties and the ability to differentiate into various cells types.
  • Adipose-derived stem cells (ASCs), a type of MSC, play an essential role in these cell-based treatments. They can modulate immune responses and regenerate tissues, making them potent allies in combating MetS symptoms and its consequences.

Treatment Approaches Targeting ER and Oxidative Stress

  • Combating ER and oxidative stress forms part of the overall strategy to treat MetS. Assuaging these stress responses could help improve insulin sensitivity, reduce inflammation, and thus help manage or even reverse several MetS-related disorders.
  • The research article reviews several such therapeutic approaches, emphasizing their significant potential in not just treating MetS, but potentially preventing its onset in at-risk individuals.

Cite This Article

APA
Alicka M, Marycz K. (2018). The Effect of Chronic Inflammation and Oxidative and Endoplasmic Reticulum Stress in the Course of Metabolic Syndrome and Its Therapy. Stem Cells Int, 2018, 4274361. https://doi.org/10.1155/2018/4274361

Publication

Stem cells international
ISSN: 1687-966X
NlmUniqueID: 101535822
Country: United States
Language: English
Volume: 2018
Pages: 4274361
PII: 4274361

Researcher Affiliations

Alicka, Michalina
  • Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences Wroclaw, Wroclaw, Poland.
Marycz, Krzysztof
  • Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences Wroclaw, Wroclaw, Poland.
  • Faculty of Veterinary Medicine, Equine Clinic-Equine Surgery, Justus-Liebig-University, 35392 Gießen, Germany.

References

This article includes 150 references
  1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease.. Diabetes 1988 Dec;37(12):1595-607.
    doi: 10.2337/diabetes.37.12.1595pubmed: 3056758google scholar: lookup
  2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.. Circulation 2009 Oct 20;120(16):1640-5.
    doi: 10.1161/CIRCULATIONAHA.109.192644pubmed: 19805654google scholar: lookup
  3. Kaur J. A comprehensive review on metabolic syndrome.. Cardiol Res Pract 2014;2014:943162.
    doi: 10.1155/2014/943162pmc: PMC3966331pubmed: 24711954google scholar: lookup
  4. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.. Arch Intern Med 2003 Feb 24;163(4):427-36.
    doi: 10.1001/archinte.163.4.427pmc: PMC3146257pubmed: 12588201google scholar: lookup
  5. Fan AZ, Russell M, Naimi T, Li Y, Liao Y, Jiles R, Mokdad AH. Patterns of alcohol consumption and the metabolic syndrome.. J Clin Endocrinol Metab 2008 Oct;93(10):3833-8.
    doi: 10.1210/jc.2007-2788pubmed: 18628524google scholar: lookup
  6. Gohil BC, Rosenblum LA, Coplan JD, Kral JG. Hypothalamic-pituitary-adrenal axis function and the metabolic syndrome X of obesity.. CNS Spectr 2001 Jul;6(7):581-6, 589.
    doi: 10.1017/s1092852900002121pubmed: 15573024google scholar: lookup
  7. Gennuso KP, Gangnon RE, Thraen-Borowski KM, Colbert LH. Dose-response relationships between sedentary behaviour and the metabolic syndrome and its components.. Diabetologia 2015 Mar;58(3):485-92.
    doi: 10.1007/s00125-014-3453-zpubmed: 25476524google scholar: lookup
  8. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic.. Nature 2001 Dec 13;414(6865):782-7.
    doi: 10.1038/414782apubmed: 11742409google scholar: lookup
  9. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006.. Diabetes Care 2011 Jan;34(1):216-9.
    doi: 10.2337/dc10-0879pmc: PMC3005489pubmed: 20889854google scholar: lookup
  10. Gao W. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk?. Int J Obes (Lond) 2008 May;32(5):757-62.
    doi: 10.1038/sj.ijo.0803797pubmed: 18209738google scholar: lookup
  11. Kornicka K, Houston J, Marycz K. Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use.. Stem Cell Rev Rep 2018 Jun;14(3):337-345.
    doi: 10.1007/s12015-018-9809-xpmc: PMC5960487pubmed: 29611042google scholar: lookup
  12. Neeland IJ, Poirier P, Després JP. Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.. Circulation 2018 Mar 27;137(13):1391-1406.
    doi: 10.1161/CIRCULATIONAHA.117.029617pmc: PMC5875734pubmed: 29581366google scholar: lookup
  13. Marędziak M, Śmieszek A, Chrząstek K, Basinska K, Marycz K. Physical Activity Increases the Total Number of Bone-Marrow-Derived Mesenchymal Stem Cells, Enhances Their Osteogenic Potential, and Inhibits Their Adipogenic Properties.. Stem Cells Int 2015;2015:379093.
    doi: 10.1155/2015/379093pmc: PMC4488015pubmed: 26167185google scholar: lookup
  14. Marycz K, Mierzejewska K, Śmieszek A, Suszynska E, Malicka I, Kucia M, Ratajczak MZ. Endurance Exercise Mobilizes Developmentally Early Stem Cells into Peripheral Blood and Increases Their Number in Bone Marrow: Implications for Tissue Regeneration.. Stem Cells Int 2016;2016:5756901.
    doi: 10.1155/2016/5756901pmc: PMC4655293pubmed: 26664409google scholar: lookup
  15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.. JAMA 2002 Jan 16;287(3):356-9.
    doi: 10.1001/jama.287.3.356pubmed: 11790215google scholar: lookup
  16. Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity.. Arch Med Res 2008 Nov;39(8):715-28.
    doi: 10.1016/j.arcmed.2008.09.005pubmed: 18996284google scholar: lookup
  17. MacDougald OA, Mandrup S. Adipogenesis: forces that tip the scales.. Trends Endocrinol Metab 2002 Jan-Feb;13(1):5-11.
    doi: 10.1016/s1043-2760(01)00517-3pubmed: 11750856google scholar: lookup
  18. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion.. J Clin Endocrinol Metab 2007 Mar;92(3):1023-33.
    doi: 10.1210/jc.2006-1055pubmed: 17164304google scholar: lookup
  19. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Näslund E, Britton T, Concha H, Hassan M, Rydén M, Frisén J, Arner P. Dynamics of fat cell turnover in humans.. Nature 2008 Jun 5;453(7196):783-7.
    doi: 10.1038/nature06902pubmed: 18454136google scholar: lookup
  20. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance.. Cell 2001 Feb 23;104(4):531-43.
    doi: 10.1016/S0092-8674(01)00240-9pubmed: 11239410google scholar: lookup
  21. Cederberg A, Enerbäck S. Insulin resistance and type 2 diabetes--an adipocentric view.. Curr Mol Med 2003 Mar;3(2):107-25.
    doi: 10.2174/1566524033361573pubmed: 12630558google scholar: lookup
  22. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell.. Endocrinol Metab Clin North Am 2008 Sep;37(3):753-68, x-xi.
    doi: 10.1016/j.ecl.2008.07.002pmc: PMC2659415pubmed: 18775362google scholar: lookup
  23. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity.. Physiol Rev 2013 Jan;93(1):1-21.
    doi: 10.1152/physrev.00017.2012pubmed: 23303904google scholar: lookup
  24. Halberg N, Khan T, Trujillo ME, Wernstedt-Asterholm I, Attie AD, Sherwani S, Wang ZV, Landskroner-Eiger S, Dineen S, Magalang UJ, Brekken RA, Scherer PE. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.. Mol Cell Biol 2009 Aug;29(16):4467-83.
    doi: 10.1128/MCB.00192-09pmc: PMC2725728pubmed: 19546236google scholar: lookup
  25. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.. J Clin Invest 2003 Dec;112(12):1821-30.
    doi: 10.1172/jci19451pmc: PMC296998pubmed: 14679177google scholar: lookup
  26. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells.. Mol Biol Cell 2002 Dec;13(12):4279-95.
    doi: 10.1091/mbc.e02-02-0105pmc: PMC138633pubmed: 12475952google scholar: lookup
  27. Ratajczak MZ, Marycz K, Poniewierska-Baran A, Fiedorowicz K, Zbucka-Kretowska M, Moniuszko M. Very small embryonic-like stem cells as a novel developmental concept and the hierarchy of the stem cell compartment.. Adv Med Sci 2014 Sep;59(2):273-80.
    doi: 10.1016/j.advms.2014.08.001pubmed: 25170822google scholar: lookup
  28. Woo DH, Hwang HS, Shim JH. Comparison of adult stem cells derived from multiple stem cell niches.. Biotechnol Lett 2016 May;38(5):751-9.
    doi: 10.1007/s10529-016-2050-2pubmed: 26857609google scholar: lookup
  29. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes.. Diabetes 2008 Jul;57(7):1759-67.
    doi: 10.2337/db08-0180pmc: PMC2453631pubmed: 18586907google scholar: lookup
  30. Phadnis SM, Ghaskadbi SM, Hardikar AA, Bhonde RR. Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment.. Rev Diabet Stud 2009 Winter;6(4):260-70.
    doi: 10.1900/rds.2009.6.260pmc: PMC2836197pubmed: 20043038google scholar: lookup
  31. Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H, Wang KX. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.. Chin Med J (Engl) 2007 May 5;120(9):771-6.
    pubmed: 17531117
  32. Koobatian MT, Liang MS, Swartz DD, Andreadis ST. Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts.. Tissue Eng Part A 2015 Apr;21(7-8):1364-75.
    doi: 10.1089/ten.tea.2014.0535pmc: PMC4394877pubmed: 25517657google scholar: lookup
  33. Beane OS, Fonseca VC, Cooper LL, Koren G, Darling EM. Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem/stromal cells.. PLoS One 2014;9(12):e115963.
    doi: 10.1371/journal.pone.0115963pmc: PMC4277426pubmed: 25541697google scholar: lookup
  34. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies.. Tissue Eng 2001 Apr;7(2):211-28.
    doi: 10.1089/107632701300062859pubmed: 11304456google scholar: lookup
  35. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, Flake AW. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep.. Nat Med 2000 Nov;6(11):1282-6.
    doi: 10.1038/81395pubmed: 11062543google scholar: lookup
  36. Scavo LM, Karas M, Murray M, Leroith D. Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes.. J Clin Endocrinol Metab 2004 Jul;89(7):3543-53.
    doi: 10.1210/jc.2003-031682pubmed: 15240644google scholar: lookup
  37. Kornicka K, Babiarczuk B, Krzak J, Marycz K. The effect of a sol–gel derived silica coating doped with vitamin E on oxidative stress and senescence of human adipose-derived mesenchymal stem cells (AMSCs). RSC Advances 2016;6(35):29524–29537.
    doi: 10.1039/C6RA00029Kgoogle scholar: lookup
  38. Kornicka K, Marycz K, Tomaszewski KA, Marędziak M, Śmieszek A. The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation Process.. Oxid Med Cell Longev 2015;2015:309169.
    doi: 10.1155/2015/309169pmc: PMC4515302pubmed: 26246868google scholar: lookup
  39. Marędziak M, Marycz K, Tomaszewski KA, Kornicka K, Henry BM. The Influence of Aging on the Regenerative Potential of Human Adipose Derived Mesenchymal Stem Cells.. Stem Cells Int 2016;2016:2152435.
    doi: 10.1155/2016/2152435pmc: PMC4749808pubmed: 26941800google scholar: lookup
  40. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.. Stem Cells Dev 2010 May;19(5):693-706.
    doi: 10.1089/scd.2009.0365pubmed: 20067407google scholar: lookup
  41. Rizvi AA. Hypertension, obesity, and inflammation: the complex designs of a deadly trio.. Metab Syndr Relat Disord 2010 Aug;8(4):287-94.
    doi: 10.1089/met.2009.0116pubmed: 20367224google scholar: lookup
  42. Marycz K, Kornicka K, Basinska K, Czyrek A. Equine Metabolic Syndrome Affects Viability, Senescence, and Stress Factors of Equine Adipose-Derived Mesenchymal Stromal Stem Cells: New Insight into EqASCs Isolated from EMS Horses in the Context of Their Aging.. Oxid Med Cell Longev 2016;2016:4710326.
    doi: 10.1155/2016/4710326pmc: PMC4670679pubmed: 26682006google scholar: lookup
  43. Marycz K, Kornicka K, Marędziak M, Golonka P, Nicpoń J. Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy.. J Cell Mol Med 2016 Dec;20(12):2384-2404.
    doi: 10.1111/jcmm.12932pmc: PMC5134411pubmed: 27629697google scholar: lookup
  44. Marycz K, Kornicka K, Grzesiak J, Śmieszek A, Szłapka J. Macroautophagy and Selective Mitophagy Ameliorate Chondrogenic Differentiation Potential in Adipose Stem Cells of Equine Metabolic Syndrome: New Findings in the Field of Progenitor Cells Differentiation.. Oxid Med Cell Longev 2016;2016:3718468.
    doi: 10.1155/2016/3718468pmc: PMC5178365pubmed: 28053691google scholar: lookup
  45. Marycz K, Kornicka K, Szlapka-Kosarzewska J, Weiss C. Excessive Endoplasmic Reticulum Stress Correlates with Impaired Mitochondrial Dynamics, Mitophagy and Apoptosis, in Liver and Adipose Tissue, but Not in Muscles in EMS Horses.. Int J Mol Sci 2018 Jan 6;19(1).
    doi: 10.3390/ijms19010165pmc: PMC5796114pubmed: 29316632google scholar: lookup
  46. Wu CL, Diekman BO, Jain D, Guilak F. Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad: the effects of free fatty acids.. Int J Obes (Lond) 2013 Aug;37(8):1079-87.
    doi: 10.1038/ijo.2012.171pmc: PMC3582830pubmed: 23164698google scholar: lookup
  47. Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, Sirota M, Morgan AA, Chen R, Ohtsu H, Maeda S, Kadowaki T, Butte AJ. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.. Proc Natl Acad Sci U S A 2012 May 1;109(18):7049-54.
    doi: 10.1073/pnas.1114513109pmc: PMC3344989pubmed: 22499789google scholar: lookup
  48. Kodama K, Toda K, Morinaga S, Yamada S, Butte AJ. Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice.. Diabetes 2015 Mar;64(3):867-75.
    doi: 10.2337/db14-0149pmc: PMC4392898pubmed: 25294945google scholar: lookup
  49. Liu LF, Kodama K, Wei K, Tolentino LL, Choi O, Engleman EG, Butte AJ, McLaughlin T. The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue.. Diabetologia 2015 Jul;58(7):1579-86.
    doi: 10.1007/s00125-015-3603-ypubmed: 25952479google scholar: lookup
  50. Lumeng CN. Innate immune activation in obesity.. Mol Aspects Med 2013 Feb;34(1):12-29.
    doi: 10.1016/j.mam.2012.10.002pmc: PMC3888776pubmed: 23068074google scholar: lookup
  51. Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.. Trends Cell Biol 2012 Nov;22(11):557-66.
    doi: 10.1016/j.tcb.2012.08.001pubmed: 22995730google scholar: lookup
  52. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.. Nature 2012 Feb 1;482(7384):179-85.
    doi: 10.1038/nature10809pmc: PMC3276682pubmed: 22297845google scholar: lookup
  53. Malagón MM, Díaz-Ruiz A, Guzmán-Ruiz R, Jiménez-Gómez Y, Moreno NR, García-Navarro S, Vázquez-Martínez R, Peinado JR. Adipobiology for novel therapeutic approaches in metabolic syndrome.. Curr Vasc Pharmacol 2013 Nov;11(6):954-67.
    pubmed: 24168446doi: 10.2174/15701611113116660170google scholar: lookup
  54. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction.. J Clin Invest 2011 Jun;121(6):2126-32.
    doi: 10.1172/jci58109pmc: PMC3104783pubmed: 21633181google scholar: lookup
  55. Basinska K, Marycz K, Śieszek A, Nicpoń J. The production and distribution of IL-6 and TNF-a in subcutaneous adipose tissue and their correlation with serum concentrations in Welsh ponies with equine metabolic syndrome.. J Vet Sci 2015;16(1):113-20.
    doi: 10.4142/jvs.2015.16.1.113pmc: PMC4367141pubmed: 25269712google scholar: lookup
  56. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance.. J Intern Med 1999 Jun;245(6):621-5.
    doi: 10.1046/j.1365-2796.1999.00490.xpubmed: 10395191google scholar: lookup
  57. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.. J Biol Chem 2003 Nov 14;278(46):45777-84.
    doi: 10.1074/jbc.m301977200pubmed: 12952969google scholar: lookup
  58. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance.. Nature 2002 Nov 21;420(6913):333-6.
    doi: 10.1038/nature01137pubmed: 12447443google scholar: lookup
  59. Jernås M, Palming J, Sjöholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjögren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.. FASEB J 2006 Jul;20(9):1540-2.
    doi: 10.1096/fj.05-5678fjepubmed: 16754744google scholar: lookup
  60. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis.. Am J Physiol Heart Circ Physiol 2005 May;288(5):H2031-41.
    doi: 10.1152/ajpheart.01058.2004pubmed: 15653761google scholar: lookup
  61. Azzawi M, Hasleton P. Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease.. Cardiovasc Res 1999 Sep;43(4):850-9.
    doi: 10.1016/s0008-6363(99)00138-8pubmed: 10615412google scholar: lookup
  62. Testa R, Olivieri F, Bonfigli AR, Sirolla C, Boemi M, Marchegiani F, Marra M, Cenerelli S, Antonicelli R, Dolci A, Paolisso G, Franceschi C. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.. Diabetes Res Clin Pract 2006 Mar;71(3):299-305.
    doi: 10.1016/j.diabres.2005.07.007pubmed: 16140413google scholar: lookup
  63. Bernberg E, Ulleryd MA, Johansson ME, Bergström GM. Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE-/- mice.. Atherosclerosis 2012 Apr;221(2):359-65.
    doi: 10.1016/j.atherosclerosis.2011.11.041pubmed: 22284955google scholar: lookup
  64. Kim YD, Kim YH, Cho YM, Kim DK, Ahn SW, Lee JM, Chanda D, Shong M, Lee CH, Choi HS. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models.. Diabetologia 2012 May;55(5):1482-94.
    doi: 10.1007/s00125-012-2494-4pubmed: 22349108google scholar: lookup
  65. Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.. Int J Med Sci 2016;13(1):25-38.
    doi: 10.7150/ijms.13800pmc: PMC4716817pubmed: 26816492google scholar: lookup
  66. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.. J Clin Invest 2006 Jun;116(6):1494-505.
    doi: 10.1172/jci26498pmc: PMC1459069pubmed: 16691291google scholar: lookup
  67. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr. CCR2 modulates inflammatory and metabolic effects of high-fat feeding.. J Clin Invest 2006 Jan;116(1):115-24.
    doi: 10.1172/JCI24335pmc: PMC1307559pubmed: 16341265google scholar: lookup
  68. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes.. Diabetes Care 2002 Jul;25(7):1129-34.
    doi: 10.2337/diacare.25.7.1129pubmed: 12087009google scholar: lookup
  69. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.. J Clin Endocrinol Metab 1997 Dec;82(12):4196-200.
    doi: 10.1210/jcem.82.12.4450pubmed: 9398739google scholar: lookup
  70. Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.. J Biol Chem 2003 Apr 18;278(16):13740-6.
    doi: 10.1074/jbc.M210689200pubmed: 12560330google scholar: lookup
  71. Mancini A, Martorana GE, Magini M, Festa R, Raimondo S, Silvestrini A, Nicolotti N, Mordente A, Mele MC, Miggiano GAD, Meucci E. Oxidative stress and metabolic syndrome: Effects of a natural antioxidants enriched diet on insulin resistance.. Clin Nutr ESPEN 2015 Apr;10(2):e52-e60.
    doi: 10.1016/j.clnesp.2014.11.002pubmed: 28531459google scholar: lookup
  72. Sies H. Oxidative stress: oxidants and antioxidants.. Exp Physiol 1997 Mar;82(2):291-5.
    doi: 10.1113/expphysiol.1997.sp004024pubmed: 9129943google scholar: lookup
  73. Armutcu F, Ataymen M, Atmaca H, Gurel A. Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome.. Clin Chem Lab Med 2008;46(6):785-90.
    doi: 10.1515/CCLM.2008.166pubmed: 18601599google scholar: lookup
  74. Palmieri VO, Grattagliano I, Portincasa P, Palasciano G. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome.. J Nutr 2006 Dec;136(12):3022-6.
    doi: 10.1093/jn/136.12.3022pubmed: 17116714google scholar: lookup
  75. Folmer V, Soares JC, Rocha JB. Oxidative stress in mice is dependent on the free glucose content of the diet.. Int J Biochem Cell Biol 2002 Oct;34(10):1279-85.
    doi: 10.1016/s1357-2725(02)00065-1pubmed: 12127578google scholar: lookup
  76. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome.. J Clin Invest 2004 Dec;114(12):1752-61.
    doi: 10.1172/JCI21625pmc: PMC535065pubmed: 15599400google scholar: lookup
  77. McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome.. Clin Dermatol 2018 Jan-Feb;36(1):14-20.
    doi: 10.1016/j.clindermatol.2017.09.004pubmed: 29241747google scholar: lookup
  78. Elhadd TA, Kennedy G, Hill A, McLaren M, Newton RW, Greene SA, Belch JJ. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease.. Diabetes Metab Res Rev 1999 Nov-Dec;15(6):405-11.
    doi: 10.1002/(SICI)1520-7560(199911/12)15:6<405::AID-DMRR69>3.0.CO;2-Hpubmed: 10634966google scholar: lookup
  79. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients.. Diabete Metab 1992 Jul-Aug;18(4):264-71.
    pubmed: 1459313
  80. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications.. Clin Sci (Lond) 1996 Apr;90(4):255-60.
    doi: 10.1042/cs0900255pubmed: 8777831google scholar: lookup
  81. De Pauw A, Tejerina S, Raes M, Keijer J, Arnould T. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations.. Am J Pathol 2009 Sep;175(3):927-39.
    doi: 10.2353/ajpath.2009.081155pmc: PMC2731113pubmed: 19700756google scholar: lookup
  82. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance.. Nature 2006 Apr 13;440(7086):944-8.
    doi: 10.1038/nature04634pubmed: 16612386google scholar: lookup
  83. Konrad T, Vicini P, Kusterer K, Höflich A, Assadkhani A, Böhles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes.. Diabetes Care 1999 Feb;22(2):280-7.
    doi: 10.2337/diacare.22.2.280pubmed: 10333946google scholar: lookup
  84. Berridge MJ. Neuronal calcium signaling.. Neuron 1998 Jul;21(1):13-26.
    doi: 10.1016/S0896-6273(00)80510-3pubmed: 9697848google scholar: lookup
  85. Brodsky JL, Skach WR. Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems.. Curr Opin Cell Biol 2011 Aug;23(4):464-75.
    doi: 10.1016/j.ceb.2011.05.004pmc: PMC3154734pubmed: 21664808google scholar: lookup
  86. Cao SS, Kaufman RJ. Targeting endoplasmic reticulum stress in metabolic disease.. Expert Opin Ther Targets 2013 Apr;17(4):437-48.
    doi: 10.1517/14728222.2013.756471pubmed: 23324104google scholar: lookup
  87. Lindholm D, Korhonen L, Eriksson O, Kõks S. Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease.. Front Cell Dev Biol 2017;5:48.
    doi: 10.3389/fcell.2017.00048pmc: PMC5423914pubmed: 28540288google scholar: lookup
  88. Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress.. Nat Cell Biol 2011 Mar;13(3):184-90.
    doi: 10.1038/ncb0311-184pmc: PMC3107571pubmed: 21364565google scholar: lookup
  89. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.. Mol Cell Biol 2003 Nov;23(21):7448-59.
    doi: 10.1128/mcb.23.21.7448-7459.2003pmc: PMC207643pubmed: 14559994google scholar: lookup
  90. Hetz C, Chevet E, Oakes SA. Proteostasis control by the unfolded protein response.. Nat Cell Biol 2015 Jul;17(7):829-38.
    doi: 10.1038/ncb3184pmc: PMC5546321pubmed: 26123108google scholar: lookup
  91. Upton JP, Wang L, Han D, Wang ES, Huskey NE, Lim L, Truitt M, McManus MT, Ruggero D, Goga A, Papa FR, Oakes SA. IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2.. Science 2012 Nov 9;338(6108):818-22.
    doi: 10.1126/science.1226191pmc: PMC3742121pubmed: 23042294google scholar: lookup
  92. Cao SS, Kaufman RJ. Unfolded protein response.. Curr Biol 2012 Aug 21;22(16):R622-6.
    doi: 10.1016/j.cub.2012.07.004pubmed: 22917505google scholar: lookup
  93. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond.. Nat Rev Mol Cell Biol 2012 Jan 18;13(2):89-102.
    doi: 10.1038/nrm3270pubmed: 22251901google scholar: lookup
  94. Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.. Science 2000 Jan 28;287(5453):664-6.
    doi: 10.1126/science.287.5453.664pubmed: 10650002google scholar: lookup
  95. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P. IRE1 signaling affects cell fate during the unfolded protein response.. Science 2007 Nov 9;318(5852):944-9.
    doi: 10.1126/science.1146361pmc: PMC3670588pubmed: 17991856google scholar: lookup
  96. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, Gunnison KM, Mori K, Sadighi Akha AA, Raden D, Kaufman RJ. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins.. PLoS Biol 2006 Nov;4(11):e374.
    doi: 10.1371/journal.pbio.0040374pmc: PMC1634883pubmed: 17090218google scholar: lookup
  97. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response.. Nat Rev Mol Cell Biol 2007 Jul;8(7):519-29.
    doi: 10.1038/nrm2199pubmed: 17565364google scholar: lookup
  98. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O, Cheung P, Merali S. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals.. Diabetes 2008 Sep;57(9):2438-44.
    doi: 10.2337/db08-0604pmc: PMC2518495pubmed: 18567819google scholar: lookup
  99. Gregor MF, Yang L, Fabbrini E, Mohammed BS, Eagon JC, Hotamisligil GS, Klein S. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss.. Diabetes 2009 Mar;58(3):693-700.
    doi: 10.2337/db08-1220pmc: PMC2646068pubmed: 19066313google scholar: lookup
  100. Flamment M, Hajduch E, Ferré P, Foufelle F. New insights into ER stress-induced insulin resistance.. Trends Endocrinol Metab 2012 Aug;23(8):381-90.
    doi: 10.1016/j.tem.2012.06.003pubmed: 22770719google scholar: lookup
  101. Ghemrawi R, Battaglia-Hsu SF, Arnold C. Endoplasmic Reticulum Stress in Metabolic Disorders.. Cells 2018 Jun 19;7(6).
    doi: 10.3390/cells7060063pmc: PMC6025008pubmed: 29921793google scholar: lookup
  102. Oslowski CM, Urano F. Measuring ER stress and the unfolded protein response using mammalian tissue culture system.. Methods Enzymol 2011;490:71-92.
    doi: 10.1016/b978-0-12-385114-7.00004-0pmc: PMC3701721pubmed: 21266244google scholar: lookup
  103. Rojas-Rivera D, Delvaeye T, Roelandt R, Nerinckx W, Augustyns K, Vandenabeele P, Bertrand MJM. When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157.. Cell Death Differ 2017 Jun;24(6):1100-1110.
    doi: 10.1038/cdd.2017.58pmc: PMC5442476pubmed: 28452996google scholar: lookup
  104. Tsaytler P, Harding HP, Ron D, Bertolotti A. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis.. Science 2011 Apr 1;332(6025):91-4.
    doi: 10.1126/science.1201396pubmed: 21385720google scholar: lookup
  105. Guthrie LN, Abiraman K, Plyler ES, Sprenkle NT, Gibson SA, McFarland BC, Rajbhandari R, Rowse AL, Benveniste EN, Meares GP. Attenuation of PKR-like ER Kinase (PERK) Signaling Selectively Controls Endoplasmic Reticulum Stress-induced Inflammation Without Compromising Immunological Responses.. J Biol Chem 2016 Jul 22;291(30):15830-40.
    doi: 10.1074/jbc.M116.738021pmc: PMC4957064pubmed: 27226638google scholar: lookup
  106. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes.. J Clin Invest 2002 Feb;109(4):525-32.
    doi: 10.1172/jci200214550pmc: PMC150879pubmed: 11854325google scholar: lookup
  107. Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase.. Science 1996 May 31;272(5266):1347-9.
    doi: 10.1126/science.272.5266.1347pubmed: 8650547google scholar: lookup
  108. Han D, Lerner AG, Vande Walle L, Upton JP, Xu W, Hagen A, Backes BJ, Oakes SA, Papa FR. IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates.. Cell 2009 Aug 7;138(3):562-75.
    doi: 10.1016/j.cell.2009.07.017pmc: PMC2762408pubmed: 19665977google scholar: lookup
  109. Bouchecareilh M, Higa A, Fribourg S, Moenner M, Chevet E. Peptides derived from the bifunctional kinase/RNase enzyme IRE1α modulate IRE1α activity and protect cells from endoplasmic reticulum stress.. FASEB J 2011 Sep;25(9):3115-29.
    doi: 10.1096/fj.11-182931pubmed: 21680894google scholar: lookup
  110. Bravo R, Gutierrez T, Paredes F, Gatica D, Rodriguez AE, Pedrozo Z, Chiong M, Parra V, Quest AF, Rothermel BA, Lavandero S. Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics.. Int J Biochem Cell Biol 2012 Jan;44(1):16-20.
    doi: 10.1016/j.biocel.2011.10.012pmc: PMC4118286pubmed: 22064245google scholar: lookup
  111. Plaisance V, Brajkovic S, Tenenbaum M, Favre D, Ezanno H, Bonnefond A, Bonner C, Gmyr V, Kerr-Conte J, Gauthier BR, Widmann C, Waeber G, Pattou F, Froguel P, Abderrahmani A. Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL.. PLoS One 2016;11(9):e0163046.
    doi: 10.1371/journal.pone.0163046pmc: PMC5026355pubmed: 27636901google scholar: lookup
  112. Chong WC, Shastri MD, Eri R. Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Nexus Implicated in Bowel Disease Pathophysiology.. Int J Mol Sci 2017 Apr 5;18(4).
    doi: 10.3390/ijms18040771pmc: PMC5412355pubmed: 28379196google scholar: lookup
  113. van der Vlies D, Makkinje M, Jansens A, Braakman I, Verkleij AJ, Wirtz KW, Post JA. Oxidation of ER resident proteins upon oxidative stress: effects of altering cellular redox/antioxidant status and implications for protein maturation.. Antioxid Redox Signal 2003 Aug;5(4):381-7.
    doi: 10.1089/152308603768295113pubmed: 13678525google scholar: lookup
  114. Creighton TE, Hillson DA, Freedman RB. Catalysis by protein-disulphide isomerase of the unfolding and refolding of proteins with disulphide bonds.. J Mol Biol 1980 Sep 5;142(1):43-62.
    doi: 10.1016/0022-2836(80)90205-3pubmed: 7431409google scholar: lookup
  115. Chakravarthi S, Bulleid NJ. Glutathione is required to regulate the formation of native disulfide bonds within proteins entering the secretory pathway.. J Biol Chem 2004 Sep 17;279(38):39872-9.
    doi: 10.1074/jbc.m406912200pubmed: 15254031google scholar: lookup
  116. Ferrari DM, Söling HD. The protein disulphide-isomerase family: unravelling a string of folds.. Biochem J 1999 Apr 1;339 ( Pt 1)(Pt 1):1-10.
    doi: 10.1042/bj3390001pmc: PMC1220120pubmed: 10085220google scholar: lookup
  117. Hagiwara M, Nagata K. Redox-dependent protein quality control in the endoplasmic reticulum: folding to degradation.. Antioxid Redox Signal 2012 May 15;16(10):1119-28.
    doi: 10.1089/ars.2011.4495pubmed: 22229892google scholar: lookup
  118. Chaudhari N, Talwar P, Parimisetty A, Lefebvre d'Hellencourt C, Ravanan P. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress.. Front Cell Neurosci 2014;8:213.
    doi: 10.3389/fncel.2014.00213pmc: PMC4114208pubmed: 25120434google scholar: lookup
  119. Cao SS, Luo KL, Shi L. Endoplasmic Reticulum Stress Interacts With Inflammation in Human Diseases.. J Cell Physiol 2016 Feb;231(2):288-94.
    doi: 10.1002/jcp.25098pmc: PMC4659393pubmed: 26201832google scholar: lookup
  120. Li X. Endoplasmic reticulum stress regulates inflammation in adipocyte of obese rats via toll-like receptors 4 signaling.. Iran J Basic Med Sci 2018 May;21(5):502-507.
    doi: 10.22038/IJBMS.2018.27346.6674pmc: PMC6000215pubmed: 29922431google scholar: lookup
  121. Kawasaki N, Asada R, Saito A, Kanemoto S, Imaizumi K. Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue.. Sci Rep 2012;2:799.
    doi: 10.1038/srep00799pmc: PMC3495279pubmed: 23150771google scholar: lookup
  122. Hasnain SZ, Borg DJ, Harcourt BE, Tong H, Sheng YH, Ng CP, Das I, Wang R, Chen AC, Loudovaris T, Kay TW, Thomas HE, Whitehead JP, Forbes JM, Prins JB, McGuckin MA. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.. Nat Med 2014 Dec;20(12):1417-26.
    doi: 10.1038/nm.3705pubmed: 25362253google scholar: lookup
  123. Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA, Donath MY. Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets.. Proc Natl Acad Sci U S A 2004 May 25;101(21):8138-43.
    doi: 10.1073/pnas.0305683101pmc: PMC419570pubmed: 15141093google scholar: lookup
  124. Donath MY, Böni-Schnetzler M, Ellingsgaard H, Ehses JA. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.. Physiology (Bethesda) 2009 Dec;24:325-31.
    doi: 10.1152/physiol.00032.2009pubmed: 19996363google scholar: lookup
  125. Miani M, Barthson J, Colli ML, Brozzi F, Cnop M, Eizirik DL. Endoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1β-induced apoptosis via Bim/A1 imbalance.. Cell Death Dis 2013 Jul 4;4(7):e701.
    doi: 10.1038/cddis.2013.236pmc: PMC3730410pubmed: 23828564google scholar: lookup
  126. Brozzi F, Nardelli TR, Lopes M, Millard I, Barthson J, Igoillo-Esteve M, Grieco FA, Villate O, Oliveira JM, Casimir M, Bugliani M, Engin F, Hotamisligil GS, Marchetti P, Eizirik DL. Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms.. Diabetologia 2015 Oct;58(10):2307-16.
    doi: 10.1007/s00125-015-3669-6pubmed: 26099855google scholar: lookup
  127. Nakajima S, Chi Y, Gao K, Kono K, Yao J. eIF2α-Independent Inhibition of TNF-α-Triggered NF-κB Activation by Salubrinal.. Biol Pharm Bull 2015;38(9):1368-74.
    doi: 10.1248/bpb.b15-00312pubmed: 26328492google scholar: lookup
  128. Coudriet GM, Delmastro-Greenwood MM, Previte DM, Marré ML, O'Connor EC, Novak EA, Vincent G, Mollen KP, Lee S, Dong HH, Piganelli JD. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.. Antioxidants (Basel) 2017 Nov 1;6(4).
    doi: 10.3390/antiox6040085pmc: PMC5745495pubmed: 29104232google scholar: lookup
  129. Farinha JB, Steckling FM, Stefanello ST, Cardoso MS, Nunes LS, Barcelos RP, Duarte T, Kretzmann NA, Mota CB, Bresciani G, Moresco RN, Duarte MM, Dos Santos DL, Soares FA. Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise training in women with metabolic syndrome.. Sports Med Open 2015;1(1):19.
    doi: 10.1186/s40798-015-0011-2pmc: PMC5005613pubmed: 26284160google scholar: lookup
  130. Ozcan L, Tabas I. Role of endoplasmic reticulum stress in metabolic disease and other disorders.. Annu Rev Med 2012;63:317-28.
    doi: 10.1146/annurev-med-043010-144749pmc: PMC3290993pubmed: 22248326google scholar: lookup
  131. Matsushita K, Dzau VJ. Mesenchymal stem cells in obesity: insights for translational applications.. Lab Invest 2017 Oct;97(10):1158-1166.
    doi: 10.1038/labinvest.2017.42pubmed: 28414326google scholar: lookup
  132. Zang L, Hao H, Liu J, Li Y, Han W, Mu Y. Mesenchymal stem cell therapy in type 2 diabetes mellitus.. Diabetol Metab Syndr 2017;9:36.
    doi: 10.1186/s13098-017-0233-1pmc: PMC5433043pubmed: 28515792google scholar: lookup
  133. Home-ClinicalTrials.gov. April 2018, https://clinicaltrials.gov/
  134. Kadam S, Muthyala S, Nair P, Bhonde R. Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes.. Rev Diabet Stud 2010 Summer;7(2):168-82.
    doi: 10.1900/rds.2010.7.168pmc: PMC2989789pubmed: 21060975google scholar: lookup
  135. Kadam SS, Sudhakar M, Nair PD, Bhonde RR. Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules.. Cytotherapy 2010 Dec;12(8):982-91.
    doi: 10.3109/14653249.2010.509546pubmed: 20807019google scholar: lookup
  136. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators.. J Cell Biochem 2006 Aug 1;98(5):1076-84.
    doi: 10.1002/jcb.20886pubmed: 16619257google scholar: lookup
  137. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing.. PLoS One 2008 Apr 2;3(4):e1886.
    doi: 10.1371/journal.pone.0001886pmc: PMC2270908pubmed: 18382669google scholar: lookup
  138. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.. Exp Hematol 2003 Oct;31(10):890-6.
    doi: 10.1016/S0301-472X(03)00110-3pubmed: 14550804google scholar: lookup
  139. Hematti P, Kim J, Stein AP, Kaufman D. Potential role of mesenchymal stromal cells in pancreatic islet transplantation.. Transplant Rev (Orlando) 2013 Jan;27(1):21-9.
    doi: 10.1016/j.trre.2012.11.003pubmed: 23290684google scholar: lookup
  140. Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.. Nat Immunol 2014 Nov;15(11):1009-16.
    doi: 10.1038/ni.3002pubmed: 25329189google scholar: lookup
  141. Zhao K, Hao H, Liu J, Tong C, Cheng Y, Xie Z, Zang L, Mu Y, Han W. Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy.. Cell Death Dis 2015 Sep 17;6(9):e1885.
    doi: 10.1038/cddis.2015.230pmc: PMC4650435pubmed: 26379190google scholar: lookup
  142. Valle-Prieto A, Conget PA. Human mesenchymal stem cells efficiently manage oxidative stress.. Stem Cells Dev 2010 Dec;19(12):1885-93.
    doi: 10.1089/scd.2010.0093pubmed: 20380515google scholar: lookup
  143. Silva WA Jr, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. The profile of gene expression of human marrow mesenchymal stem cells.. Stem Cells 2003;21(6):661-9.
    doi: 10.1634/stemcells.21-6-661pubmed: 14595126google scholar: lookup
  144. Stolzing A, Scutt A. Effect of reduced culture temperature on antioxidant defences of mesenchymal stem cells.. Free Radic Biol Med 2006 Jul 15;41(2):326-38.
    doi: 10.1016/j.freeradbiomed.2006.04.018pubmed: 16814114google scholar: lookup
  145. Ebert R, Ulmer M, Zeck S, Meissner-Weigl J, Schneider D, Stopper H, Schupp N, Kassem M, Jakob F. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro.. Stem Cells 2006 May;24(5):1226-35.
    doi: 10.1634/stemcells.2005-0117pubmed: 16424399google scholar: lookup
  146. Calió ML, Marinho DS, Ko GM, Ribeiro RR, Carbonel AF, Oyama LM, Ormanji M, Guirao TP, Calió PL, Reis LA, Simões Mde J, Lisbôa-Nascimento T, Ferreira AT, Bertoncini CR. Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model.. Free Radic Biol Med 2014 May;70:141-54.
    doi: 10.1016/j.freeradbiomed.2014.01.024pubmed: 24525001google scholar: lookup
  147. Chandravanshi B, Bhonde RR. Shielding Engineered Islets With Mesenchymal Stem Cells Enhance Survival Under Hypoxia.. J Cell Biochem 2017 Sep;118(9):2672-2683.
    doi: 10.1002/jcb.25885pubmed: 28098405google scholar: lookup
  148. Wojtas E, Zachwieja A, Zwyrzykowska A, KupczyńSki R, Marycz K. The application of mesenchymal progenitor stem cells for the reduction of oxidative stress in animals. Turkish Journal of Biology 2017;41:12–19.
    doi: 10.3906/biy-1603-13google scholar: lookup
  149. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noël D, Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.. Blood 2003 Nov 15;102(10):3837-44.
    doi: 10.1182/blood-2003-04-1193pubmed: 12881305google scholar: lookup
  150. Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, Sayegh MH, Abdi R. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.. J Immunol 2009 Jul 15;183(2):993-1004.
    doi: 10.4049/jimmunol.0900803pmc: PMC3895445pubmed: 19561093google scholar: lookup

Citations

This article has been cited 25 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.